PetIQ, Inc. (PETQ) Misses Q4 EPS by 20c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
PetIQ, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results
February 28, 2023 4:05 PM ESTFull Year 2022 Net Sales and Adjusted EBITDA In-Line with Company GuidanceUpdates Adjusted EBITDA MethodologyReports Record Annual Cash from Operations of $48.0 MillionCompletes Complementary, Margin Accretive Acquisition of Rocco & Roxie Provides First Quarter 2023 and Full Year 2023 Outlook
EAGLE, Idaho, Feb. 28, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (PetIQ or the Company) (Nasdaq: PETQ), a leading pet medication and wellness company, today reported financial results for the fourth quarter and full year ended December 31, 2022.
Cord Christensen, PetIQs Chairman & CEO, commented, We are pleased to report net... More
